XML 20 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenue $ 886,093 $ 779,796 $ 486,920
Cost of revenue 653,983 635,693 367,496
Gross profit 232,110 144,103 119,424
Operating expenses      
Technology and development 84,297 69,765 53,797
Marketing 54,881 76,710 44,061
General and administrative(1) [1] 92,140 76,874 65,500
Total operating expenses 231,318 223,349 163,358
Income (loss) from operations 792 (79,246) (43,934)
Interest income 2,074 7,146 5,416
Interest expense (19,495) (8,928) (3,681)
Other income (loss), net (1,898) 223 221
Net loss (18,527) (80,805) (41,978)
Temporary Equity, Dividends, Adjustment (4,454) 0 0
Net loss attributable to common stock—basic (22,981) (80,805) (41,978)
Net loss attributable to common stock—diluted $ (22,981) $ (80,805) $ (41,978)
Net loss per share attributable to common stock—basic and diluted (in dollars per share) $ (0.23) $ (0.88) $ (0.49)
Weighted average shares of common stock—basic and diluted (in shares) 98,574,529 91,583,533 85,669,039
Net loss $ (22,981) $ (80,805) $ (41,978)
Other comprehensive income      
Foreign currency translation adjustments (3) 33 0
Unrealized gain on available-for-sale securities 172 9 0
Other Comprehensive Income (Loss), Tax 169 42 0
Total comprehensive loss (18,358) (80,763) (41,978)
Service      
Revenue 674,345 539,288 441,927
Cost of revenue 437,484 390,504 320,883
Product      
Revenue 211,748 240,508 44,993
Cost of revenue $ 216,499 $ 245,189 $ 46,613
[1] (1) Includes direct and incremental costs related to COVID-19 of $7,864, which are partially offset by $1,348 in employee retention credits allowed under the CARES Act, for the year ended December 31, 2020.